Published in Hepatitis Weekly, November 24th, 1997
"As the pathogenic mechanisms of autoimmune hepatitis are elucidated, additional therapies can be anticipated," Albert J. Czaja of Rochester, Minnesota's Mayo Clinic said in a presentation given at the 48th Annual Meeting of the American Association for the Study of Liver Diseases, held November 7-11, 1997, in Chicago, Illinois.
"These treatments will undoubtedly have highly focused actions directed at the most critical pathogenic pathways. They will likely emerge from the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.